ABX Pentra 120 Retic SPS
Overview
- Microsampling of 50 µl whole blood from primary tubes.
- User-definable smearing criteria.
- Choice of staining protocols.
- Validation station with cytology atlas.
- Up to 120 samples/hour.
Features
ABX Pentra 120 Retic SPS Concept and technology
- Methods of measurement: Cytochemistry, impedance, absorbance and flow cytometry (Eosinofix* and LMNE matrix).
- Reticulocyte profile:Thiazole orange, fluorescence, impedance, Argon-ion laser (Retix* and retic matrix).
- Balance Concept: Automatic control of the leukocyte count based on 3 independent channels.
- DHSS*: Focused flow cytometry and sequential measurement (impedance and absorbance).
- Automatic re-run of samples : Selective and programmable (hematology parameters and smears).
- Rotative mixing of samples : Smooth and efficient
- Wedge smear tape cartridge: Optimized slide preparation and no contamination.
- Dedicated slide staining wells : No contamination and minimum dye consumption.
- Liquid valves* ABX (no pinch valves): Reliability and volume accuracy
*ABX patents
Manufactured by HORIBA ABX SAS
Specifications
Technical
Weight | 170 kg |
Power supply | 90/240 V - 50/60 Hz - 800 VA. |
Dimensions | 50 x 91 x 70 (H x W x D) cm (Pentra 120 module). |
Electrical safety standards | IEC 601-1 CE Mark. |
Throughout | 120 tests/hour |
Physical | Temparature range of 18-32°C. 20-85% relative humidity (non-condensing). |
Performance | Produces classic wedge smear with significant monolayer. |
Specific parameters | Drop volume, smearing angle, smearing speed. |
Staining Rotor | 32 staining wells. |
Samples
120 tests/hour (closed tube) | |
|---|---|
Processing | Up to 120 sliedes per hour. |
Staining | May Grünwald-Giemsa. |
Volume | Closed tube mode : 50 µl |
Operating sample mode | Vertical rack loader. |
Identification | Auto-printing of demographics (user definable) on slide with resilient ink. |
Parameters (36) | WBC, RBC, HGB, HCT, MCV, RDW, MCH, MCHC, PLT, MPV, PCT, PDW % and #. LYM, MON, NEU, EOS, BAS0. RET %, RET #, RETH %,RETM %, RETL %, IMM %, CRC%, IRF %, MRV, MFI% |
Plus | ALY = Atypical Lymphocytes (% and #) |
Graphics | High resolution leucocyte differential matrix |
Stability | Up to 48 hours |
Results
Parameters | Presicion (cv %) | Linearity |
|---|---|---|
WBC | < 2% (at 10.10³/mm³) | 0-150.10³/mm³ |
RBC | < 2% (at 5.0.106/mm³ ) | 0-8,1.106/mm³ |
HGB | < 1% (at 15 g/dl) | 0-25 g/dl |
HCT | < 2% (at 45%) | 0-80% |
PLT (whole blood) | < 5% (at 300.10³/mm³) | 0-2000.10³/mm³ |
PLT (PLT concentrate) | 0-4500.10³/mm³ | |
LYM | 3.58% (at 23,3%) | 0-100% |
MON | 8,11% (at 8,2%) | 0-100% |
NEU | 2% (at 65,4%) | 0-100% |
EOS | 11,45% (at 2,4%) | 0-100% |
BAS | 30% | 0-100% |
Parameters | Presicion (cv %) | Linearity |
|---|---|---|
WBC | < 95% | 0-150 x 103 / mm3 |
RBC | < 95% | 0-8,1.106/mm³ |
HGB | < 95% | 0-25 g/dl |
HCT | < 95% | 0-80% |
PLT (whole blood) | < 95% | 0-2000.10³/mm³ |
PLT (PLT concentrate) | < 95% | 0-4500.10³/mm³ |
LYM | < 95% | -- |
MON | < 95% | -- |
NEU | < 95% | -- |
EOS | < 95% | -- |
BAS | < 95% | -- |
